Sunday 18 October 2026
Export ADGM’s income statement to Excel — free account
Adagio Medical Holdings, Inc.
ADGM Healthcare Medical Devices
Adagio Medical Holdings, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $602,000.00, up 100.7% from fiscal 2023. In the quarter to June 2026, revenue fell 33.5%, EPS fell 15.4%, free cash flow fell 12.9% and total debt rose 46.6%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
0.10
0.00
0.00%
Follow ADGM
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
0.48 | 2.08 | 1.51 | 1.02 | |
Current Ratio |
0.84 | 2.44 | 1.85 | 1.41 | |
Net Debt/EBITDA |
(2.99) | (1.03) | (2.00) | (3.61) | |
Debt/Assets |
67.17% | 48.64% | 58.19% | 73.30% | |
Debt/Equity |
(16.15) | 1.70 | 4.00 | (59.85) | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.30 | 1.25 | 0.59 | 0.78 | |
Capex/Depreciation |
(2.72) | 2.07 | (0.01) | (0.03) | |
Interest Coverage |
(7.64) | (5.23) | (6.68) | (6.13) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.66 | 0.48 | 0.53 | 0.62 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.20) | (0.25) | (0.19) | (0.24) | |
Capex per Share |
(0.03) | 0.03 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.23) | (0.22) | (0.19) | (0.24) | |
Cash per Share |
0.30 | 1.03 | 0.58 | 0.35 | |
Shareholders Equity per Share |
(0.09) | 0.75 | 0.26 | (0.02) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(0.09) | 0.75 | 0.26 | (0.02) | |
Free Cash Flow |
(3.53) | (3.65) | (4.13) | (5.27) | |
Working Capital |
(1.56) | 11.85 | 7.28 | 3.13 | |
Capital Expenditures |
(0.52) | 0.49 | 0.00 | (0.01) | |
Net Current Asset Value |
(24.71) | (10.77) | (17.73) | (23.61) | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Payables |
2.72 | 1.96 | 1.93 | 1.01 | |
Average Inventory |
2.84 | 2.12 | 1.96 | 1.91 | |
Average Assets |
69.37 | 45.85 | 40.32 | 34.88 | |
Average Common Equity |
37.62 | 16.16 | 9.06 | 4.13 |
Columns are period end dates